OHI250117P48000
- 0.00
- 0.000.00%
Omega Healthcare Investors Inc Newsroom
Jefferies Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $40
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Announces Target Price $39
Omega Healthcare Price Target Maintained With a $45.00/Share by BMO Capital
Omega Healthcare Raised to Outperform From Market Perform by BMO Capital
BMO Capital Upgrades Omega Healthcare Investors Inc(OHI.US) to Buy Rating, Maintains Target Price $45
Omega Healthcare Is Maintained at Sector Perform by RBC Capital
Omega Healthcare Invts Analyst Ratings
BofA Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $43
RBC Capital Adjusts Price Target on Omega Healthcare Investors to $43 From $39, Says 'Better Investment Trends Driving Stronger Growth Outlook'; Keeps Sector Perform Rating
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
BNP Paribas Upgrades Omega Healthcare Investors Inc(OHI.US) to Buy Rating, Raises Target Price to $49
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Maintains Target Price $45
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $45
Omega Healthcare Is Maintained at Market Perform by BMO Capital
Omega Healthcare Price Target Raised to $45.00/Share From $44.00 by BMO Capital
Omega Healthcare Invts Analyst Ratings
Wells Fargo Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Raises Target Price to $43
Deutsche Bank Adjusts Omega Healthcare Investors Price Target to $46 From $38, Maintains Buy Rating
Omega Healthcare Price Target Raised to $39.00/Share From $33.00 by Scotiabank
Scotiabank Maintains Sector Perform on Omega Healthcare Invts, Raises Price Target to $39